Effective Phagocytosis and Killing of Candida albicans via Targeting FcγRI (CD64) or FcαRI (CD89) on Neutrophils
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Invasive fungal infections are an increasing problem for immunocompromised patients. As an approach to improve targeting of polymorphonuclear leukocytes (PMNL) toward Candida albicans, the effect of bispecific antibodies (BsAbs) directed against C. albicans and either FcalphaRI or FcgammaRI was evaluated. Control PMNL and in vivo granulocyte colony-stimulating factor (G-CSF)-primed PMNL served as effector cells. A new radiometric killing assay for measuring candidacidal activity was developed to facilitate quantification of PMNL-mediated killing of C. albicans. BsAbs directed to either FcgammaRI (CD64) or FcalphaRI (CD89) on human PMNL effectively enhanced both phagocytosis and killing of C. albicans in vitro. Fungicidal activity triggered via FcgammaRI required in vivo priming with G-CSF, whereas FcalphaRI-mediated activity was not dependent on this growth factor. Furthermore, PMNL from human FcgammaRI-transgenic mice effectively phagocytosed and eliminated C. albicans in the presence of BsAbs. These results document the capacity of FcR-directed BsAbs and G-CSF to trigger antifungal immune responses.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hospital-Acquired Candidemia: The Attributable Mortality and Excess Length of Stay
Wey, S. B. (1988) · Archives of Internal Medicine · doi:10.1001/archinte.1988.00380120094019 · Cited by 831 · cited 1×
“and increasing resistance, the overall mortality among immunocompromised patients is high (~6007o) [2-4].”
BackgroundNolla-Salas, J., Sitges-Serra, A., León-Gil, C., Martínez-González, J., León-Regidor, M. A., Ibán˜ez-Lucí, P., & Torres-Rodríguez, J. M. (1997) · Intensive Care Medicine · doi:10.1007/s001340050286 · Cited by 263
Inoculation candidiasis in a murine model of severe combined immunodeficiency syndrome
Mahanty, S., Greenfield, R. A., Joyce, W. A., & Kincade, P. W. (1988) · Infection and Immunity · doi:10.1128/iai.56.12.3162-3166.1988 · Cited by 67
Cited by
Phagocytosis of Microbes: Complexity in Action
Underhill, D. M., & Ozinsky, A. (2002) · Annual Review of Immunology · doi:10.1146/annurev.immunol.20.103001.114744 · Cited by 1,124
The Cell Biology of Phagocytosis
Flannagan, R. S., Jaumouillé, V., & Grinstein, S. (2012) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011811-132445 · Cited by 1,023
Phagocytosis: Our Current Understanding of a Universal Biological Process
Uribe-Querol, E., & Rosales, C. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01066 · Cited by 651
Phagocytosis: A Fundamental Process in Immunity
Rosales, C., & Uribe-Querol, E. (2017) · BioMed Research International · doi:10.1155/2017/9042851 · Cited by 552
Phagocytosis: Receptors, signal integration, and the cytoskeleton
Freeman, S. A., & Grinstein, S. (2014) · Immunological Reviews · doi:10.1111/imr.12212 · Cited by 548
Monteiro, R. C., & van de Winkel, J. G. J. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141011 · Cited by 531
Self-citationvan Egmond, M., Damen, C. A., van Spriel, A. B., Vidarsson, G., van Garderen, E., & van de Winkel, J. G. J. (2001) · Trends in Immunology · doi:10.1016/s1471-4906(01)01873-7 · Cited by 282
Self-citationIgA: Structure, Function, and Developability
de Sousa-Pereira, P., & Woof, J. M. (2019) · Antibodies · doi:10.3390/antib8040057 · Cited by 264
miR-24, miR-30b, and miR-142-3p Regulate Phagocytosis in Myeloid Inflammatory Cells
Naqvi, A. R., Fordham, J. B., & Nares, S. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1401893 · Cited by 124
Metadata
- Authors
- van Spriel, A. B., van den Herik‐Oudijk, I. E., van Sorge, N. M., Vilé, H. A., van Strijp, J. A. G., & van de Winkel, J. G. J.
- Venue
- The Journal of Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 1999-03
- Volume
- 179
- Issue
- 3
- Pages
- 661-669
- ISSN
- 0022-1899 (ISSN-L)
- 1537-6613
- OpenAlex
- W2127714004
- Cited by
- 73
- References
- 3
- FWCI
- 4.19
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.